ASTRAZENECA MALAYSIA SDN BHD

AstraZeneca Malaysia Sdn Bhd is the Malaysian subsidiary of AstraZeneca PLC, a global, science-led biopharmaceutical company. In Malaysia, the company focuses on the discovery, development, and commercialization of prescription medicines across key therapeutic areas such as Oncology, Cardiovascular, Renal & Metabolism (CVRM), and Respiratory & Immunology. Its operations involve the marketing, sales, and distribution of AstraZeneca's global product portfolio to patients and healthcare professionals throughout Malaysia. The company also engages in local clinical trials, medical affairs, and regulatory activities to support the Malaysian healthcare system and improve patient outcomes.

AstraZeneca Malaysia Sdn Bhd is primarily a **trading company**. It is responsible for the sales, marketing, and distribution of pharmaceutical products in Malaysia, which are manufactured by the global AstraZeneca network. It does not operate as a primary manufacturing factory for finished pharmaceutical products within Malaysia.

AstraZeneca Malaysia Sdn Bhd primarily focuses on prescription medicines across various therapeutic areas. Key products include:

* Oncology medications (e.g., for breast cancer, lung cancer)

* Cardiovascular and metabolic disease medications (e.g., for diabetes, heart failure)

* Respiratory disease medications (e.g., for asthma, COPD)

* Immunology medications

* Vaccines (including COVID-19 vaccine during the pandemic period)